View in EDS HTML Full Text PDF Full Text

Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.

Saved in:
Bibliographic Details
Title: Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.
Authors: Zheng, Zhijian1,2 (AUTHOR), Wu, Ming3 (AUTHOR), Li, Hongyan4 (AUTHOR), Xu, Wenxia2 (AUTHOR), Yang, Mengxiang2 (AUTHOR), Pan, Kailing2 (AUTHOR), Ni, Yuqi2 (AUTHOR), Jiang, Ting5 (AUTHOR), Zheng, Hongjuan1 (AUTHOR), Jin, Xiayun1 (AUTHOR), Zhang, Yanfei6 (AUTHOR), Ding, Linchao7 (AUTHOR) d.linchao@gmail.com, Fu, Jianfei1 (AUTHOR) fujianfei@zju.edu.cn
Source: BMC Medicine. 4/3/2023, Vol. 21 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17417015
DOI:10.1186/s12916-023-02826-6